Ugur Sahin Vermögen Ugur Sahin Vermögen - Uğur şahin is a German, immunologist and Biontech CEO oncologist, who helped develop one of the m...

Ugur Sahin Vermögen

Ugur Sahin Vermögen
Ugur Sahin Vermögen

Ugur Sahin Vermögen - Uğur şahin is a German, immunologist and Biontech CEO oncologist, who helped develop one of the main vaccines against Covid-19. The main research fields of it are the investigation and immunology of cancer.

Ugur Sahin Vermögen
Ugur Sahin Vermögen

The family of şahin, originally from Turkey, moved to Germany when he was four years old. He grew up in Cologne and studied medicine at the University of Cologne, completing a doctorate thesis in cancer immunotherapy. Initially it remained at the Academy, in the patient's attention as a doctor of oncohematology and conducting research in university hospitals in Saarland and Zurich and, finally, founding a research group at the University of Mainz in 2000. It became a professor of experimental oncology In 2006. In 2001, in 2001, while maintaining his position at Mainz University, he began to participate in business activities, together with two pharmaceutical companies in 2001 and 2008 with his partner and spouse Özlem Türeci. The second of these companies, Biontech, developed one of the main vaccines used to combat the Covid-19 pandemia together with Pfizer Inc in 2020. As a result of the company's increase in value, şahin and Türeci became the first Germans with roots Turks between list of 100 richest people from Germany.